Neurology Devices are specialized surgical devices used for the treatment of disease or conditions of the Central Nervous System (CNS) and spine. Hydrocephalus Shunts allow excess Cerebrospinal Fluid (CSF) to drain to another area of the body. GlobalData uses proprietary data and analytics to provide a comprehensive report on the hydrocephalus shunts devices market, including market shares of different players within Ireland. Buy the latest report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Ireland Hydrocephalus Shunts Market Share

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

In 2023, GlobalData’s Market Model methodology determined that the leading player in the hydrocephalus shunts market in Ireland was Integra LifeSciences followed by Medtronic, Aesculap, Natus Medical and Sophysa.

Hydrocephalus Valves and Hydrocephalus Catheters are covered in this category. Hydrocephalus Valves regulate the flow of CSF out of the brain’s ventricles. Two types of Hydrocephalus Catheters are considered in the market: Antimicrobial Catheters and Standard Catheters.

The value of the hydrocephalus shunts devices market within Ireland was expected to be over $0.7m in 2023.

For the latest complete market share analysis of hydrocephalus shunts device market in Ireland, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.